Exabis Library
Welcome to the e-CCO Library!
P098: Mucosal Microbiota Composition Predicts Infliximab Response in Inflammatory Bowel Diseases
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P098: Novel drug candidate for the treatment of Inflammatory Bowel Disease with unique mechanisms of action
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P098: Oregonin inhibits intestinal epithelial injury by modulating heme oxygenase-1
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P098: Role of serum lysol oxidase like 2 in Crohn's disease and modulation to biological treatment
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P099 Neutrophil gelatinase-associated lipocalin (NGAL) as biomarker in collagenous colitis
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P099: Altered intrinsic brain function in Crohn's disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P099: Evaluation of endoscopic mayo score with an artificial intelligence algorithm
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P099: IL-33 activates CD73-expressing cells promoting tumorigenesis during colitis-associated colorectal cancer
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P099: Inhibitory effect of 6-aminopyridin-3-ol analogues on TNF-α-induced monocyte-colon epithelial cell adhesion and TNBS-induced rat colitis
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P099: Patients with ulcerative colitis show increased Treg number in peripheral blood after 1 year of anti-TNF therapy
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P099: Postprandial intestinal motility and related physiology in active small-bowel Crohn’s disease
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P099: Serum proteomic analysis reveals novel biomarkers associated with disease activity in pediatric patients with Crohn’s disease
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P100 CD161 levels are reduced in all subpopulations of T-cell colonic mucosal lymphocytes in inflammatory bowel disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P100: Atypical Anti-Neutrophil Cytoplasmatic Antibodies Are Antibodies Against Neutrophil Extracellular Traps: A Novel Pathophysiological Mechanism In Ulcerative Colitis
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P100: Effects of a narrow spectrum kinase inhibitor and selective kinase inhibitors on the intestinal pro-inflammatory immune response in ulcerative colitis
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P100: Guanosine prevents nuclear factor-κB nuclear translocation ameliorating experimental colitis in rats
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P100: Higher yield of serrated and adenomatous dysplasia detected with chromoendoscopy when compared with high-definition in patients with Primary Sclerosing Cholangitis and Inflammatory colitis.
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P100: Intestinal epithelial cells under endoplasmic reticulum stress boosts serine proteolytic activity and modulates barrier function
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P100: Real-world data: the incidence, diagnosis, and management outcomes of patients with immunotherapy-related colitis in two tertiary centres
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P100: Serum inflammatory protein profiling to corroborate selection of therapy naïve moderate-to-severe pediatric Crohn’s disease patients eligible for first-line infliximab treatment
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM